Trade Liquidia Technologies, Inc. - LQDA CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.08 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.026235% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004012% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 9 |
| Open | 8.98 |
| 1-Year Change | 29.02% |
| Day's Range | 8.94 - 9.31 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Sep 6, 2024 | 9.05 | 0.20 | 2.26% | 8.85 | 9.33 | 8.85 |
| Sep 5, 2024 | 9.00 | 0.11 | 1.24% | 8.89 | 9.12 | 8.79 |
| Sep 4, 2024 | 8.90 | -0.07 | -0.78% | 8.97 | 9.18 | 8.73 |
| Sep 3, 2024 | 9.07 | -0.32 | -3.41% | 9.39 | 9.53 | 9.04 |
| Aug 30, 2024 | 9.47 | -0.05 | -0.53% | 9.52 | 9.63 | 9.44 |
| Aug 29, 2024 | 9.48 | 0.03 | 0.32% | 9.45 | 9.83 | 9.44 |
| Aug 28, 2024 | 9.45 | -0.06 | -0.63% | 9.51 | 9.64 | 9.44 |
| Aug 27, 2024 | 9.60 | 0.05 | 0.52% | 9.55 | 9.77 | 9.43 |
| Aug 26, 2024 | 9.78 | -0.13 | -1.31% | 9.91 | 9.92 | 9.53 |
| Aug 23, 2024 | 9.88 | 0.28 | 2.92% | 9.60 | 10.13 | 9.53 |
| Aug 22, 2024 | 9.57 | -0.26 | -2.64% | 9.83 | 9.83 | 9.44 |
| Aug 21, 2024 | 9.87 | 0.30 | 3.13% | 9.57 | 10.03 | 9.29 |
| Aug 20, 2024 | 9.57 | -0.07 | -0.73% | 9.64 | 10.06 | 9.31 |
| Aug 19, 2024 | 9.74 | 0.81 | 9.07% | 8.93 | 10.18 | 8.20 |
| Aug 16, 2024 | 14.07 | 0.27 | 1.96% | 13.80 | 14.32 | 13.75 |
| Aug 15, 2024 | 13.80 | 0.22 | 1.62% | 13.58 | 14.10 | 13.35 |
| Aug 14, 2024 | 13.70 | 0.18 | 1.33% | 13.52 | 13.81 | 13.27 |
| Aug 13, 2024 | 13.26 | 1.16 | 9.59% | 12.10 | 13.42 | 11.93 |
| Aug 12, 2024 | 12.17 | 0.90 | 7.99% | 11.27 | 12.18 | 11.27 |
| Aug 9, 2024 | 11.59 | 0.39 | 3.48% | 11.20 | 11.87 | 11.16 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Liquidia Technologies, Inc. Company profile
About Liquidia Corp
Liquidia Corporation is a biopharmaceutical company that is focused on the development, manufacturing and commercialization of products, which address unmet patient needs with a focus directed towards the treatment of pulmonary hypertension (PH). The Company operates, through its wholly owned subsidiaries, Liquidia Technologies and Liquidia PAH. Liquidia Technologies has developed YUTREPIA (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH). Liquidia PAH provides the commercialization for rare disease pharmaceutical products, such as generic treprostinil injection. Its United Therapeutics developed treprostinil under the brand name Remodulin. The Company’s PRINT engineering technology allows to engineer and manufacture uniform drug particles with control over the size, three-dimensional geometric shape and chemical composition of the particles. The Company operates from over 45,000 square foot facility in Morrisville, North Carolina.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Liquidia Corp revenues increased from $740K to $12.9M. Net loss decreased 42% to $34.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Research and development - Balanc decrease of 40% to $18.6M (expense), Depr of Fin Lease R/O Use Assets in SGA decrease of 80% to $267K (expense).
| Industry: | Pharmaceuticals (NEC) |
419 Davis Drive, Suite 100
Suite
MORRISVILLE
NORTH CAROLINA 27560
US
News
Introducing Newsquawk: your new in-platform newsfeed
We are very excited to announce the launch of Newsquawk in the Capital.com platform and app. This new newsfeed is designed to help you get ahead with real-time headlines, personalised stories and in-depth reports – all available directly in the platform and app, where you need them.
14:09, 20 August 2024
Jackson Hole Preview: All eyes on Powell and Gold
The key focus this week will be on Jerome Powell and any insight he may give into the future of monetary policy.
15:24, 19 August 2024
All eyes on inflation: US and UK CPI take centre stage
Just over a month has gone by since the latest CPI data was released in the US and so much has happened since.
14:41, 13 August 2024
European stocks face resistance in their attempt to recover
European stocks struggle to recover as the tech sector faces continued downside pressure in Asia.
13:56, 9 August 2024
Global selloff continues on US economy fears
Thursday’s rise in jobless claims led to a market meltdown in the US stock market as investors became concerned that the Federal Reserve made the wrong decision by keeping rates unchanged on Wednesday.
14:40, 5 August 2024
FOMC PREVIEW
Markets believe the Federal reserve will continue to leave their monetary policy unchanged at the meeting next week.
14:09, 1 August 2024
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024People also watch
Still looking for a broker you can trust?
Join the 640,000+ traders worldwide that chose to trade with Capital.com